| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +16.8M | 98.2% | $20.00 | +$337M |
| Sells | 10 | -311K | 1.8% | $24.64 | -$7.66M |
| Net | -9 | +16.5M | 96.4% | +$329M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Roivant Sciences Ltd. | Director, 10%+ Owner | $1.93B | +$337M | +21.1% | Jan 13, 2025 |
| Peter Salzmann | Chief Executive Officer, Director | $17.5M | -$3.31M | -15.9% | Apr 16, 2025 |
| Frank Torti | Director | $16.7M | Apr 1, 2025 | ||
| Julia G. Butchko | Chief Development Officer | $14.3M | -$321K | -2.2% | Aug 21, 2024 |
| Mark S. Levine | Chief Legal Officer | $8.12M | -$805K | -9.02% | Nov 20, 2024 |
| William L. Macias | Chief Medical Officer | $7.45M | -$560K | -6.99% | Feb 19, 2025 |
| Eva Renee Barnett | Chief Financial Officer | $5.91M | -$1.22M | -17.1% | Apr 16, 2025 |
| Melanie Gloria | Chief Operating Officer | $3.72M | Apr 1, 2025 | ||
| Christopher Van Tuyl | Chief Legal Officer | $3.21M | Apr 1, 2025 | ||
| Michael Geffner | Chief Medical Officer | $2.96M | -$427K | -12.6% | Apr 9, 2025 |
| Jay S. Stout | Chief Technology Officer | $2.74M | -$485K | -15% | Apr 9, 2025 |
| George V. Migausky | Director | $2.74M | Apr 1, 2025 | ||
| Douglas J. Hughes | Director | $2.71M | -$155K | -5.4% | Apr 1, 2025 |
| Atul Pande | Director | $2.45M | -$221K | -8.27% | Apr 1, 2025 |
| Andrew J. Fromkin | Director | $2.16M | -$157K | -6.77% | Apr 1, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|